Fund Tracker
NOVARTINDNSEHealthcarePharmaceuticals & Biotechnology

Novartis India Limited

₹1,965.60NSE close, 25 Sep 2026
Data as of10 sources, each card shows its own date
MF: Aug 2026 portfolios (monthly), 20 AMCsShares outstanding and close: NSE, 25 Sep 2026Delivery: NSE bhavcopy, 25 Sep 2026 · 30 days collectedDeals: NSE deal files, 25 Sep 2026 · collected since 25 Sep 2026SLBM: NSE, 25 Sep 2026 · 30 days collectedMTF: NSE, 24 Sep 2026 · 29 days collectedFlags: NSE, 25 Sep 2026FPI: NSE shareholding filings collectedPledge: NSE shareholding filings collectedInsider: Disclosures filed 29 Jun 2026 to 26 Sep 2026 (collected since 3 May 2026)
MF holding, % of equity
0.62%▼ −0.06 pp
Aug 2026 · change vs Jul 2026 over 20 AMCs with both months, all schemes
FPI holding, % of equity
—
Not in the filings collected
Fund houses holding
2no change
0 entered, 0 exited · Aug 2026 · index funds hidden
Promoter pledge
—
Not in the filings collected

What changed

2 tracked fund houses held NOVARTIND in Aug 2026. None entered or exited.

All tracked schemes together held 1.53 lakh shares, 0.62% of equity, worth ₹23.8 cr at the end of Aug 2026.

Index and arbitrage funds held 0.00% of equity; they are left out of the fund-house counts.

MF houses

Aug 2026
2no change m/m
New0Added1Reduced1Exited0

Top buyer HDFC Mutual Fund, +0.02% of equity. Top seller Bandhan Mutual Fund, −0.09% of equity. Index and arbitrage funds hidden.

AMC portfolios, Aug 2026 · 20 AMCs trackedSource: AMC monthly portfolios (SEBI disclosure) 2 fund houses →

Named FPIs at 1% or more

No shareholding pattern for NOVARTIND has been collected yet.
NSE shareholding filings collectedSource: NSE shareholding pattern filings (XBRL), quarterly

Insider and promoter

29 Jun 2026 to 26 Sep 2026
No insider or promoter trade in NOVARTIND was disclosed 29 Jun 2026 to 26 Sep 2026.
Disclosures filed 29 Jun 2026 to 26 Sep 2026 (collected since 3 May 2026)Source: NSE insider trading disclosures (SEBI PIT, XBRL)

Bulk and block deals

25 Sep 2026
No bulk or block deals in NOVARTIND on 25 Sep 2026.
NSE deal files, 25 Sep 2026 · collected since 25 Sep 2026Source: NSE bulk.csv and block.csv, daily

Promoter pledge

No shareholding pattern for NOVARTIND has been collected yet.
NSE shareholding filings collectedSource: NSE shareholding pattern filings (XBRL), quarterly

SLBM borrowing

25 Sep 2026
NSE listed no SLBS open position for NOVARTIND on any of the 30 days collected, 14 Aug 2026 to 25 Sep 2026. No SLBM trades in NOVARTIND on 25 Sep 2026.
NSE, 25 Sep 2026 · 30 days collectedSource: NSE SLBS open positions (slb_openpos) and SLBM bhavcopy (SLBM_BC), daily

MTF book

24 Sep 2026
57,198 sh▲ +2,043 vs 23 Sep 2026

percentile 100 of 29 days collected · ₹12.2 cr financed

57,198 shares, 0.23% of equity in the margin trading book at the end of 24 Sep 2026; that day sits at percentile 100 of 29 days collected.

NSE, 24 Sep 2026 · 29 days collectedSource: NSE margin trading disclosure (mrg_trading), daily

Delivery

25 Sep 2026
36.5%▼ −3.1 pp vs 20-day average

20-day average 39.7% · percentile 30 of 30 days collected

36.5% of the shares traded on 25 Sep 2026 were delivered, against a 20-day average of 39.7%; that day sits at percentile 30 of 30 days collected.

NSE bhavcopy, 25 Sep 2026 · 30 days collectedSource: NSE security-wise delivery file (sec_bhavdata_full), daily

Red flags

25 Sep 2026
No F&O

NOVARTIND has no F&O contracts in NSE's combined open-interest file, so the F&O ban does not apply. NSE listed NOVARTIND under no ASM or GSM stage on 25 Sep 2026. Pledge invocations are not collected yet.

NSE, 25 Sep 2026Source: NSE F&O ban file, combined OI (MWPL), surveillance indicators (REG1_IND), daily